Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · IEX Real-Time Price · USD
21.36
+0.51 (2.45%)
At close: Jul 19, 2024, 4:00 PM
21.35
-0.01 (-0.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $1.99 billion as of July 22, 2024. Its market cap has increased by 324.29% in one year.
Market Cap
1.99B
Enterprise Value
1.47B
1-Year Change
324.29%
Ranking
Category
Stock Price
$21.36
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $1.99B, an increase of 162.13%. That is a compound annual growth rate of 33.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.00B | 187.34% |
| Dec 29, 2023 | 694.30M | 22.86% |
| Dec 30, 2022 | 565.10M | -24.97% |
| Dec 31, 2021 | 753.20M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 2.07B |
| Premier | 2.05B |
| BrightSpring Health Services | 2.00B |
| Catalyst Pharmaceuticals | 2.00B |
| 10x Genomics | 2.00B |
| Immunocore Holdings | 1.99B |
| Recursion Pharmaceuticals | 1.99B |
| NovoCure | 1.98B |